Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses - Wikidata - wikimedia - TriplyDB

Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses

Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses

http://www.wikidata.org/entity/Q34281482

about

Diabetes mellitus and renal failure: Prevention and management Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease Updates on the management of diabetes in dialysis patients Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease Estimating Average Glucose Levels from Glycated Albumin in Patients with End-Stage Renal Disease Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study Association of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipients.Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.Peritoneal dialysis in diabetics: there is room for more.A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: A1C remains the gold standard outcome predictor in diabetic dialysis patients. Counterpoint.Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis.Derivation and validation of a renal risk score for people with type 2 diabetes Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients.Using hemoglobin A1c to derive mean blood glucose in peritoneal dialysis patients.Diets and enteral supplements for improving outcomes in chronic kidney disease.Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon.Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes.Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?Hemoglobin a1c in the ESRD population: status report.Haemodialysis-induced hypoglycaemia and glycaemic disarrays.Antidiabetic Therapy in End-Stage Renal Disease.Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease.Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus.Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes.The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis.A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease.Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis.Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes.The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients.Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis.

P2860

Q26768488-B64F42A6-73B7-44DF-8A19-813264007B06 Q26827458-A139F259-9ECF-4EE8-946E-310CA8D97DA0 Q27024782-3C0FAB1D-6173-4DF7-AE5D-3792B729C77C Q28548561-81734403-1E6E-4039-ACE0-DB62A6B4ACD5 Q28972420-2593327B-AD64-4662-81FB-8B48FB63E6E4 Q30422123-08D4E420-AAE7-41F4-92AA-E15D3E734533 Q30423628-82153231-7E11-4D6A-AF9E-03B4FDB807E6 Q30427058-64252AEA-CBE2-4944-B8A5-774E649F163F Q35371053-15E0F649-2706-4609-B486-B3699E2B7FDD Q36047184-5DE8130D-EE51-48AF-9949-CF7F90F25A02 Q36255395-9AA04DEE-EAC9-479A-8FC6-8880902129CC Q37193467-A2EBF23F-0539-4554-A94E-2112B5AEDE53 Q37260188-8C4EF0A3-8FD7-490D-8669-1AAD4C4BA26B Q37352182-0305B207-1038-411E-B60A-B5C9492F2BCC Q37421911-3DCC0BD8-65F9-4010-8F00-931D97616EFA Q38013676-5DBFDBE4-48BD-4FE4-9638-BF587DCCEBC7 Q38054558-043FC443-A4A1-4E6A-88A4-6EA8FF3584A2 Q38182542-4505CF01-D6A0-443F-AF09-CB643AF545B4 Q38231450-D2B58F57-6FB5-48C3-BA4F-7D5879C5BC66 Q38409082-11F6649F-978F-4DEE-B5DA-1611669CE01A Q38433245-88363DAD-4DD8-4B1A-A5BB-2B0CD8B6E94F Q38543658-FF50A912-A419-46C4-B725-34AB078BB028 Q38737636-AF76EACB-DCF1-4F82-847C-61E813DF487A Q40168373-F6673F18-0568-4AE1-92C5-966FCE7A1AED Q41109810-18BA05C7-ACDC-49CB-B744-EB2C602F2F10 Q41808839-A02873C6-0B13-4D5D-B73E-287B85597DF7 Q42286738-F2372334-C26D-495A-BD85-CFA4ECC8EDA6 Q46231385-9AEBCCE5-15DF-4EEA-A154-9D1E6EFDAF77 Q46428227-8C4895B8-F067-48D9-8CBE-6D6CCC881B3B Q46854252-C7BEAF20-5597-4056-897A-BE571F6A0716 Q48041579-724F8111-3BB4-4D3D-BF65-C2D6C5672FBC

P2860

Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses

http://www.wikidata.org/entity/Q34281482

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Glycemic control and extended ...... e-dependent Cox model analyses

@ast

Glycemic control and extended ...... e-dependent Cox model analyses

@en

Glycemic control and extended ...... e-dependent Cox model analyses

@nl

type

label

Glycemic control and extended ...... e-dependent Cox model analyses

@ast

Glycemic control and extended ...... e-dependent Cox model analyses

@en

Glycemic control and extended ...... e-dependent Cox model analyses

@nl

prefLabel

Glycemic control and extended ...... e-dependent Cox model analyses

@ast

Glycemic control and extended ...... e-dependent Cox model analyses

@en

Glycemic control and extended ...... e-dependent Cox model analyses

@nl

P1433

Q34281482-ACAF9458-8345-4A84-BBB7-A746D1F930C4

P1476

Q34281482-93DC6282-D96D-4C83-BF61-9C096D69B4DE

P2093

Q34281482-010C579D-96BC-4815-9452-ED166AA2FE36

Q34281482-02432A61-A111-41D1-A009-46CAFFCFCF99

Q34281482-36E528A6-4084-40CF-A910-C9DBE82ADFE2

Q34281482-70D15746-448A-4686-8B2E-34015741E36E

Q34281482-FE014C4D-82A5-43B7-87FF-B783CD425197

P2860

Q34281482-078B919B-D808-4AAB-95E7-F2D1920F3AF4

Q34281482-0C456CE2-72C0-4458-AC86-3F737B9AADDE

Q34281482-112446D9-A8CB-4ED9-96F7-3A8028274647

Q34281482-18DC4FFF-192F-4FCC-83A7-4B45EA6FE4BF

Q34281482-2121DB45-B60E-48AF-841D-49D08E2A9DC8

Q34281482-25D2E0E8-9200-49C2-9367-0FF728D8701F

Q34281482-26277D19-3539-442C-BB80-465E0313C7A1

Q34281482-381D7B54-DCA0-4038-A597-9B869E58A719

Q34281482-3B75A6B3-753D-4033-8589-4270B7EF1FDD

Q34281482-3CB30579-95F4-425D-A136-BC4105A1F23E

P304

Q34281482-78AAE5FA-1B1F-452A-81D4-5FD6DB00455F

P31

Q34281482-D746AE77-0189-4094-9936-9C85756F04E4

P356

Q34281482-AC1900E9-E032-4912-905E-930C99F2FE14

P433

Q34281482-89F116AE-757E-434C-A146-621393A1FFE9

P478

Q34281482-E69AB295-90D5-4561-B9FF-CA0FA0B2F57D

P577

Q34281482-16371DC5-3E63-4B28-BBE7-E7B6428BE2F4

P5875

Q34281482-1D572835-18B5-470E-A8C2-E163CBC6F743

P698

Q34281482-1326716E-F6E9-4774-B4CA-CE789508C08A

P921

Q34281482-36928A30-4350-4260-88A5-AE2091ADBFAA

P932

Q34281482-1BCBB8D0-02EB-456A-A931-F8F0B0B2920E

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Glycemic control and extended ...... e-dependent Cox model analyses

@en

P2093

Eduardo Lacson

http://www.w3.org/2001/XMLSchema#string

J Michael Lazarus

http://www.w3.org/2001/XMLSchema#string

Mark E Williams

http://www.w3.org/2001/XMLSchema#string

Raymond Hakim

http://www.w3.org/2001/XMLSchema#string

Weiling Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians

Motor vehicle crashes in diabetic patients with tight glycemic control: a population-based case control analysis

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Hypoglycaemia in Type 2 diabetes.

Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes.

The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis.

P304

1595-1601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.09301209

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45423949

http://www.w3.org/2001/XMLSchema#string

P698

20671217

http://www.w3.org/2001/XMLSchema#string

P921

P932

2974399

http://www.w3.org/2001/XMLSchema#string